Guselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experience.

Federico BardazziFilippo VivianiYuri MerliVito Di LerniaFrancesca PeccerilloAndrea ContiClaudia LasagniMichela TabanelliSimone D'AdamioSergio Di NuzzoChiara CortellazziFederica Filippi

Published in: Expert opinion on biological therapy (2022)

Our findings confirm guselkumab as an appropriate therapeutic option in routine clinical practice, especially when dealing with complex patients with comorbidities or previous failure to biologic treatments.

Keyphrases

clinical practice
cross sectional
rheumatoid arthritis
randomized controlled trial
atopic dermatitis
placebo controlled